不同剂量雷马唑仑对老年患者镇静质量和心功能的影响:一项双盲随机对照研究。

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Frontiers in Cardiovascular Medicine Pub Date : 2025-01-06 eCollection Date: 2024-01-01 DOI:10.3389/fcvm.2024.1453608
Liu Minghong, Qizhu Feng, Huichun Chen, Ju Li, Jun Shi
{"title":"不同剂量雷马唑仑对老年患者镇静质量和心功能的影响:一项双盲随机对照研究。","authors":"Liu Minghong, Qizhu Feng, Huichun Chen, Ju Li, Jun Shi","doi":"10.3389/fcvm.2024.1453608","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.</p><p><strong>Methods: </strong>A total of 135 ASA I-III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T<sub>0</sub>), after induction (T<sub>1</sub>) and after intubation (T<sub>2</sub>), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.</p><p><strong>Results: </strong>At T<sub>1</sub> and T<sub>2</sub>, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences (<i>P</i> < 0.05). At T<sub>1</sub> and T<sub>2</sub>, the BIS value in Group M was lower than that in Group L, with a statistically significant difference (<i>P</i> < 0.05). However, there was no statistically significant difference (<i>P</i> <i>></i> 0<i>.</i>05) in BIS values between Group M and Group H; At T<sub>1</sub> and T<sub>2</sub>, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences (<i>P</i> < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences (<i>P</i> < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>General anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"11 ","pages":"1453608"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743649/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study.\",\"authors\":\"Liu Minghong, Qizhu Feng, Huichun Chen, Ju Li, Jun Shi\",\"doi\":\"10.3389/fcvm.2024.1453608\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.</p><p><strong>Methods: </strong>A total of 135 ASA I-III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T<sub>0</sub>), after induction (T<sub>1</sub>) and after intubation (T<sub>2</sub>), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.</p><p><strong>Results: </strong>At T<sub>1</sub> and T<sub>2</sub>, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences (<i>P</i> < 0.05). At T<sub>1</sub> and T<sub>2</sub>, the BIS value in Group M was lower than that in Group L, with a statistically significant difference (<i>P</i> < 0.05). However, there was no statistically significant difference (<i>P</i> <i>></i> 0<i>.</i>05) in BIS values between Group M and Group H; At T<sub>1</sub> and T<sub>2</sub>, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences (<i>P</i> < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences (<i>P</i> < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>General anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.</p>\",\"PeriodicalId\":12414,\"journal\":{\"name\":\"Frontiers in Cardiovascular Medicine\",\"volume\":\"11 \",\"pages\":\"1453608\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743649/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Cardiovascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fcvm.2024.1453608\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2024.1453608","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:观察不同剂量静脉诱导贝磺酸雷马唑仑对老年患者镇静质量和心功能的影响。方法:选取ASA I-III级择期腹腔镜胆囊切除术患者135例。他们被随机分为三组。低剂量组(L组):苯磺酸雷马唑仑0.2 mg/kg;中剂量组(M组):苯磺酸雷马唑仑0.3 mg/kg;高剂量组(H组):苯磺酸雷马唑仑0.4 mg/kg。每组45例。记录诱导前(T0)、诱导后(T1)、插管后(T2)的血压、心率、BIS值、心功能,以及意识丧失时间、镇静持续时间、拔管及不良事件。结果:T1、T2时,M组收缩压、舒张压均低于L组,高于H组,差异有统计学意义(P 1、T2时,M组BIS值低于L组,M组与H组BIS值差异有统计学意义(P P < 0.05);在T1、T2时,M组的心输出量、每搏量均高于H组,而全身血管阻力均低于H组,差异均有统计学意义(P P P P0.3 mg/kg贝磺酸雷马唑仑全麻诱导用于老年腹腔镜胆囊切除术患者镇静质量好,可实现快速插管,对心功能影响最小,总体安全性较好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study.

Background: We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.

Methods: A total of 135 ASA I-III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T0), after induction (T1) and after intubation (T2), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.

Results: At T1 and T2, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences (P < 0.05). At T1 and T2, the BIS value in Group M was lower than that in Group L, with a statistically significant difference (P < 0.05). However, there was no statistically significant difference (P> 0.05) in BIS values between Group M and Group H; At T1 and T2, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences (P < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences (P < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences (P < 0.05).

Conclusions: General anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
期刊最新文献
Case Report: A rare case of Noonan syndrome with multiple lentigines manifesting as cardiac enlargement. Editorial: Insights in cardiac rhythmology 2023. Nonlinear association between red cell distribution width/albumin ratio and peripheral arterial disease in the NHANES: a cross-section study with propensity score matching analysis. Progress on long non-coding RNAs in calcific aortic valve disease. Machine learning analysis of emerging risk factors for early-onset hypertension in the Tlalpan 2020 cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1